Singapore markets closed

LLY Dec 2022 310.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
23.65+2.38 (+11.19%)
As of 10:26AM EDT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?

    Shares of Eli Lilly (NYSE: LLY) recently ticked higher in response to encouraging words from a Wall Street analyst who follows the pharmaceutical industry. Colin Bristow at UBS, an investment bank, thinks this is the most attractive pharma stock you can buy right now. Is Bristow right about Eli Lilly?

  • Reuters

    Eli Lilly sued for age discrimination by U.S. agency EEOC

    Eli Lilly and Co was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the drugmaker of illegally refusing to hire older workers for sales representative jobs because of their age. The complaint said Lilly's violations began after Stephen Fry, its senior vice president for human resources and diversity, lamented during an April 2017 "Leadership Town Hall" that its sales force was skewed toward older workers, with 20% fewer "millennials" than the American workforce. According to the EEOC, Fry suggested that the lack of millennials was a problem, and the Indianapolis-based company would target 40% "Early Career" hiring.

  • Zacks

    Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know

    Eli Lilly (LLY) closed the most recent trading day at $307.50, moving -1.27% from the previous trading session.